0001493152-23-000026.txt : 20230103
0001493152-23-000026.hdr.sgml : 20230103
20230103062009
ACCESSION NUMBER: 0001493152-23-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221229
FILED AS OF DATE: 20230103
DATE AS OF CHANGE: 20230103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dritschilo Anatoly
CENTRAL INDEX KEY: 0001945126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41488
FILM NUMBER: 23500104
MAIL ADDRESS:
STREET 1: SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
STREET 2: ONE RESEARCH COURT, SUITE 450
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shuttle Pharmaceuticals Holdings, Inc.
CENTRAL INDEX KEY: 0001757499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE RESEARCH COURT
STREET 2: SUITE 450
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 2404034212
MAIL ADDRESS:
STREET 1: ONE RESEARCH COURT
STREET 2: SUITE 450
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
ownership.xml
X0306
4
2022-12-29
0
0001757499
Shuttle Pharmaceuticals Holdings, Inc.
SHPH
0001945126
Dritschilo Anatoly
C/O SHUTTLE PHARMACEUTICALS HOLDINGS
ONE RESEARCH COURT, SUITE 450
ROCKVILLE
MD
20850
1
1
1
0
CEO and Chairman
COMMON STOCK
2022-12-29
4
S
0
8372
1.605
D
1085200
D
COMMON STOCK
3204407
I
By spouse
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 22,748 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
Consists of 1,085,200 shares of common stock held directly by the Reporting Person.
Consists of 3,204,407 shares of common stock held by the Reporting Person's spouse, over which the Reporting Person disclaims any beneficial ownership or control. The inclusion in this report of the 3,204,407 shares held by the Reporting Person's spouse shall in no way be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/ Anatoly Dritschilo
2023-01-03